Researchers at the University of Edinburgh harnessed machine learning to identify 21 potential drug candidates, significantly streamlining the screening process. Notably, three natural compounds—jincton, periplascin, and oleandrin—were found to effectively eliminate senescent cells without harming healthy ones, marking a breakthrough in drug discovery. This collaborative effort highlights the potential of AI to revolutionize early-stage drug development, particularly for complex diseases.
